Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The origin and application of experimental autoimmune encephalomyelitis.
Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with MS.
Teriflunomide for multiple sclerosis.
Episode 40 with Dr. Raj Kapoor on a clinical trial of phenytoin
USPTO list of patent term extensions
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Demyelination and Remyelination: From Mechanism to Therapy
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model.
The Role of the Gut Microbiome on Multiple Sclerosis Risk and Progression
The Oxford English Corpus: Facts about the language, The Story of Dictionaries
Episode 43 with Dr. May Han on following patients through the course of their disease
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Primary progressive multiple sclerosis-why we are failing.
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
American Academy of Neurology Fall Conference 2014
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
Petite but Potent
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.

Pages